7 terminated. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Terminated 7 |
Follow bifeprunox: new trials by email Literature Review of bifeprunox trials Research Report on bifeprunox
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Bifeprunox in Patients With Schizophrenia Bifeprunox, Placebo, Quetiapine - Schizophrenia | Phase 3 | Terminated | H. Lundbeck A/S | 346 | 2008-06-01 | 2010-09-27 |
| Efficacy of Bifeprunox in Patients With Schizophrenia Bifeprunox, Placebo, Quetiapine - Schizophrenia | Phase 3 | Terminated | H. Lundbeck A/S | 227 | 2008-03-01 | 2010-09-27 |
| Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients Bifeprunox, Quetiapine - Schizophrenia | Phase 3 | Terminated | Solvay Pharmaceuticals | 83 | 2007-04-01 | 2008-06-04 |
| Study Evaluating Bifeprunox in Patients With Schizophrenia. Bifeprunox - Schizophrenia | Phase 3 | Terminated | Wyeth is now a wholly owned subsidiary of Pfizer | 400 | 2007-01-01 | 2013-02-11 |
| Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint bifeprunox, risperidone - Schizophrenia | Phase 3 | Terminated | Wyeth is now a wholly owned subsidiary of Pfizer | 400 | 2006-11-01 | 2013-02-11 |
| Bifeprunox Extension to Extension Study in Patients With Schizophrenia Bifeprunox - Schizophrenia | Phase 3 | Terminated | H. Lundbeck A/S | 11 | 2006-01-01 | 2013-09-16 |
| Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type bifeprunox, Placebo - Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type | Phase 3 | Terminated | Solvay Pharmaceuticals | 60 | 2005-12-01 | 2015-02-09 |
Schizophrenia (6) · Body Weight Changes (1) · Psychotic Disorders (1)
H. Lundbeck A/S (3) · Solvay Pharmaceuticals (2) · Wyeth is now a wholly owned subsidiary of Pfizer (2)
United States (4) · Czechia (2) · Estonia (2) · Poland (2) · Ukraine (2) · Argentina (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · Finland (1) · Germany (1) · Greece (1) · Hungary (1) · India (1)
2005 (2)